Covered recipient · General Payments record
SEYED A ALEALI
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2019–2020
$974.51
- Reported across 58 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.36 | 11 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $66.54 | 3 |
| Novo Nordisk AS | $44.11 | 2 |
| Incyte Corporation | $42.72 | 3 |
| E.R. Squibb & Sons, L.L.C. | $16.16 | 1 |
| Amgen Inc. | $12.50 | 1 |
| Octapharma USA, Inc. | $12.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $12.50 | 01/14/2020 | Food and Beverage | Undisputed | 06/30/2026 | 741307461 | CMS |
| Celgene Corporation | $24.05 | 01/09/2020 | Food and Beverage | Undisputed | 06/30/2026 | 728006265 | CMS |
| Celgene Corporation | $18.90 | 01/16/2020 | Food and Beverage | Undisputed | 06/30/2026 | 728006267 | CMS |
| Celgene Corporation | $23.59 | 01/28/2020 | Food and Beverage | Undisputed | 06/30/2026 | 728006269 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.16 | 03/05/2020 | Food and Beverage | Undisputed | 06/30/2026 | 728006231 | CMS |
| Incyte Corporation | $13.32 | 01/13/2020 | Food and Beverage | Undisputed | 06/30/2026 | 745799219 | CMS |
| Incyte Corporation | $13.36 | 05/28/2020 | Food and Beverage | Undisputed | 06/30/2026 | 745799275 | CMS |
| Incyte Corporation | $16.04 | 08/20/2020 | Food and Beverage | Undisputed | 06/30/2026 | 745799289 | CMS |
| Novo Nordisk Inc | $19.82 | 02/24/2020 | Food and Beverage | Undisputed | 06/30/2026 | 745132131 | CMS |
| Novo Nordisk Inc | $24.29 | 09/01/2020 | Food and Beverage | Undisputed | 06/30/2026 | 745150331 | CMS |
| Octapharma USA, Inc. | $12.33 | 01/27/2020 | Food and Beverage | Undisputed | 06/30/2026 | 735920618 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020
- Source files
- Dataset page · Bulk file · PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.